Patent details

EP3284754 Title: ANTI-CD38 ANTIBODIES

Basic Information

Publication number:
EP3284754
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP171899255
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-CD38 ANTIBODIES
French Title of Invention:
ANTICORPS ANTI-CD38
German Title of Invention:
ANTI-CD38-ANTIKÖRPER
SPC Number:

Dates

Filing date:
30/12/2011
Grant date:
04/11/2020
EP Publication Date:
21/02/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/11/2020
EP B1 Publication Date:
04/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/12/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/10/2020
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)

Agent

Name:
ARONOVA S.A.
From:
15/12/2020
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
SINGH, Shweta
Address:
United States (US)

2

Name:
BHASKAR, Vinay
Address:
United States (US)

3

Name:
ELIAS, Kathleen Ann
Address:
United States (US)

4

Name:
HAAK-FRENDSCHO, Mary
Address:
United States (US)

5

Name:
SNELL, Gyorgy Pal
Address:
United States (US)

6

Name:
DRAKE, Andrew Walling
Address:
United States (US)

7

Name:
LANDES, Gregory
Address:
United States (US)

8

Name:
KORVER, Wouter
Address:
United States (US)

Priority

1

Priority Number:
201061428699 P
Priority Date:
30/12/2010
Priority Country:
United States (US)

2

Priority Number:
201161470382 P
Priority Date:
31/03/2011
Priority Country:
United States (US)

3

Priority Number:
201161470406 P
Priority Date:
31/03/2011
Priority Country:
United States (US)

4

Priority Number:
201161485104 P
Priority Date:
11/05/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61P 35/02; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202045
Publication date:
04/11/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/11/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
16/12/2020 Power Of Attorney 1
23/12/2020 Outgoing Correspondence 1